Indrani Lall Franchini's Insider Trades & SAST Disclosures
Indrani Lall Franchini's most recent trade in Avanos Medical Inc was a trade of 12,003 Common Stock done . Disclosure was reported to the exchange on Jan. 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Indrani Lall Franchini.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Avanos Medical Inc
|
Indrani Lall Franchini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 12,003 | 16,820 (0%) | 0% | 0 | Common Stock | |
|
Alnylam Pharmaceuticals Inc
|
Franchini Indrani Lall | EVP, CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 878 | 1,754 | - | - | Restricted Stock Units | |
|
Alnylam Pharmaceuticals Inc
|
Indrani Franchini Lall | EVP, CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 878 | 4,462 (0%) | 0% | 0 | Common Stock | |
|
Alnylam Pharmaceuticals Inc
|
Franchini Lall Indrani | EVP, CLO & Secretary | Sale of securities on an exchange or to another person at price $ 154.54 per share. | 27 Feb 2024 | 142 | 4,320 (0%) | 0% | 154.5 | 21,945 | Common Stock |
|
Alnylam Pharmaceuticals Inc
|
Lall Indrani Franchini | EVP, CLO & Secretary | Sale of securities on an exchange or to another person at price $ 155.45 per share. | 27 Feb 2024 | 111 | 4,209 (0%) | 0% | 155.5 | 17,255 | Common Stock |
|
Alnylam Pharmaceuticals Inc
|
Franchini Lall Indrani | EVP, CLO & Secretary | Sale of securities on an exchange or to another person at price $ 156.38 per share. | 27 Feb 2024 | 66 | 4,143 (0%) | 0% | 156.4 | 10,321 | Common Stock |
|
Alnylam Pharmaceuticals Inc
|
Indrani Franchini Lall | EVP, CLO & Secretary | Sale of securities on an exchange or to another person at price $ 157.33 per share. | 27 Feb 2024 | 9 | 4,134 (0%) | 0% | 157.3 | 1,416 | Common Stock |
|
Alnylam Pharmaceuticals Inc
|
Lall Franchini Indrani | EVP, CLO & Secretary | Sale of securities on an exchange or to another person at price $ 158.00 per share. | 27 Feb 2024 | 1 | 4,133 (0%) | 0% | 158 | 158 | Common Stock |
|
Alnylam Pharmaceuticals Inc
|
Franchini Indrani Lall | EVP, CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 5,175 | 5,175 | - | - | Restricted Stock Units | |
|
Alnylam Pharmaceuticals Inc
|
Indrani Lall Franchini | EVP, CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 5,175 | 5,175 (0%) | 0% | 0 | Common Stock | |
|
Alnylam Pharmaceuticals Inc
|
Indrani Lall Franchini | EVP, CLO & Secretary | Sale of securities on an exchange or to another person at price $ 171.14 per share. | 01 Feb 2024 | 820 | 3,853 (0%) | 0% | 171.1 | 140,335 | Common Stock |
|
Alnylam Pharmaceuticals Inc
|
Indrani Franchini Lall | EVP, CLO & Secretary | Sale of securities on an exchange or to another person at price $ 170.01 per share. | 01 Feb 2024 | 502 | 4,673 (0%) | 0% | 170.0 | 85,345 | Common Stock |
|
Alnylam Pharmaceuticals Inc
|
Franchini Indrani Lall | EVP, CLO & Secretary | Sale of securities on an exchange or to another person at price $ 172.38 per share. | 01 Feb 2024 | 269 | 3,584 (0%) | 0% | 172.4 | 46,370 | Common Stock |
|
Alnylam Pharmaceuticals Inc
|
Indrani Lall Franchini | EVP, CLO & Secretary | Sale of securities on an exchange or to another person at price $ 210.00 per share. | 06 Apr 2023 | 3,500 | 0 (0%) | 0% | 210 | 735,000 | Common Stock |
|
Alnylam Pharmaceuticals Inc
|
Indrani Lall Franchini | EVP, CLO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 5,449 | 5,449 | - | - | Stock Option (right to buy) | |
|
Alnylam Pharmaceuticals Inc
|
Indrani Lall Franchini | EVP, CLO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 2,632 | 2,632 | - | - | Restricted Stock Units | |
|
Alnylam Pharmaceuticals Inc
|
Indrani Lall Franchini | EVP, CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 5,175 | 10,350 | - | - | Restricted Stock Units | |
|
Alnylam Pharmaceuticals Inc
|
Indrani Lall Franchini | EVP, CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 5,175 | 5,175 (0%) | 0% | 0 | Common Stock | |
|
Alnylam Pharmaceuticals Inc
|
Indrani Lall Franchini | EVP, CLO & Secretary | Sale of securities on an exchange or to another person at price $ 225.80 per share. | 01 Feb 2023 | 1,007 | 4,091 (0%) | 0% | 225.8 | 227,381 | Common Stock |
|
Alnylam Pharmaceuticals Inc
|
Indrani Lall Franchini | EVP, CLO & Secretary | Sale of securities on an exchange or to another person at price $ 226.62 per share. | 01 Feb 2023 | 586 | 3,505 (0%) | 0% | 226.6 | 132,799 | Common Stock |
|
Alnylam Pharmaceuticals Inc
|
Indrani Lall Franchini | EVP, CLO & Secretary | Sale of securities on an exchange or to another person at price $ 223.97 per share. | 01 Feb 2023 | 77 | 5,098 (0%) | 0% | 224.0 | 17,246 | Common Stock |
|
Alnylam Pharmaceuticals Inc
|
Indrani Lall Franchini | EVP, CLO & Secretary | Sale of securities on an exchange or to another person at price $ 227.40 per share. | 01 Feb 2023 | 5 | 3,500 (0%) | 0% | 227.4 | 1,137 | Common Stock |
|
Alnylam Pharmaceuticals Inc
|
Indrani Lall Franchini | EVP, CLO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 29,182 | 29,182 | - | - | Stock Option (right to buy) | |
|
Alnylam Pharmaceuticals Inc
|
Indrani Lall Franchini | EVP, CLO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 15,525 | 15,525 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges